Peter Vadas MD, PhD Consultant in Allergy and Clinical Immunology
MCAS, Systemic Mastocytosis and COVID-19
Valent P et al. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. J Allergy Clin Immunol. 2020 Aug;146(2):300-306. doi: 10.1016/j.jaci.2020.06.009.